These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 24376670
21. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi. Ulloa JL, Spina R, Casasco A, Petray PB, Martino V, Sosa MA, Frank FM, Muschietti LV. Parasit Vectors; 2017 Nov 13; 10(1):567. PubMed ID: 29132413 [Abstract] [Full Text] [Related]
22. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species. Tavares GSV, Mendonça DVC, Lage DP, Granato JDT, Ottoni FM, Ludolf F, Chávez-Fumagalli MA, Duarte MC, Tavares CAP, Alves RJ, Coimbra ES, Coelho EAF. Basic Clin Pharmacol Toxicol; 2018 Sep 13; 123(3):236-246. PubMed ID: 29481714 [Abstract] [Full Text] [Related]
30. The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence. Mittra B, Laranjeira-Silva MF, Miguel DC, Perrone Bezerra de Menezes J, Andrews NW. J Biol Chem; 2017 Jul 21; 292(29):12324-12338. PubMed ID: 28550086 [Abstract] [Full Text] [Related]
31. Perifosine Mechanisms of Action in Leishmania Species. López-Arencibia A, Martín-Navarro C, Sifaoui I, Reyes-Batlle M, Wagner C, Lorenzo-Morales J, Maciver SK, Piñero JE. Antimicrob Agents Chemother; 2017 Apr 21; 61(4):. PubMed ID: 28096161 [Abstract] [Full Text] [Related]
32. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species. Mendonça DVC, Lage DP, Calixto SL, Ottoni FM, Tavares GSV, Ludolf F, Chávez-Fumagalli MA, Schneider MS, Duarte MC, Tavares CAP, Alves RJ, Coimbra ES, Coelho EAF. Parasitol Res; 2018 Feb 21; 117(2):391-403. PubMed ID: 29248978 [Abstract] [Full Text] [Related]
33. Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing. Braga SS. Eur J Med Chem; 2019 Dec 01; 183():111660. PubMed ID: 31514064 [Abstract] [Full Text] [Related]
34. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Hart DT, Lauwers WJ, Willemsens G, Vanden Bossche H, Opperdoes FR. Mol Biochem Parasitol; 1989 Mar 01; 33(2):123-34. PubMed ID: 2542790 [Abstract] [Full Text] [Related]
35. Effect of 1,2,3-triazole salts, non-classical bioisosteres of miltefosine, on Leishmania amazonensis. Stroppa PHF, Antinarelli LMR, Carmo AML, Gameiro J, Coimbra ES, da Silva AD. Bioorg Med Chem; 2017 Jun 15; 25(12):3034-3045. PubMed ID: 28433512 [Abstract] [Full Text] [Related]
36. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB. Chowdhury SR, Kumar A, Godinho JLP, De Macedo Silva ST, Zuma AA, Saha S, Kumari N, Rodrigues JCF, Sundar S, Dujardin JC, Roy S, De Souza W, Mukhopadhyay S, Majumder HK. Biochem Pharmacol; 2017 Aug 15; 138():19-30. PubMed ID: 28483460 [Abstract] [Full Text] [Related]
37. Selective effects of Euterpe oleracea (açai) on Leishmania (Leishmania) amazonensis and Leishmania infantum. Da Silva BJM, Souza-Monteiro JR, Rogez H, Crespo-López ME, Do Nascimento JLM, Silva EO. Biomed Pharmacother; 2018 Jan 15; 97():1613-1621. PubMed ID: 29793323 [Abstract] [Full Text] [Related]
38. Antileishmanial activity of diterpene acids in copaiba oil. Santos AO, Izumi E, Ueda-Nakamura T, Dias-Filho BP, Veiga-Júnior VF, Nakamura CV. Mem Inst Oswaldo Cruz; 2013 Feb 15; 108(1):59-64. PubMed ID: 23440116 [Abstract] [Full Text] [Related]
39. Effect of itraconazole and terbinafine on Leishmania promastigotes. Zakai HA, Zimmo SKh, Fouad MA. J Egypt Soc Parasitol; 2003 Apr 15; 33(1):97-107. PubMed ID: 12739804 [Abstract] [Full Text] [Related]
40. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity. Hargrove TY, Wawrzak Z, Alexander PW, Chaplin JH, Keenan M, Charman SA, Perez CJ, Waterman MR, Chatelain E, Lepesheva GI. J Biol Chem; 2013 Nov 01; 288(44):31602-15. PubMed ID: 24047900 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]